Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

Methodology and Challenges to Recruitment to a Randomized, Double-Blind, Placebo-Controlled Trial of Oral DHEA in Postmenopausal Women

research Methodology and Challenges to Recruitment to a Randomized, Double-Blind, Placebo-Controlled Trial of Oral DHEA in Postmenopausal Women

9 citations, November 2008 in “Journal of Womens Health”

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Safety and Efficacy of Rice Bran Supercritical CO2 Extract for Hair Growth in Androgenic Alopecia: A 16-Week Double-Blind Randomized Controlled Trial

research Safety and Efficacy of Rice Bran Supercritical CO2 Extract for Hair Growth in Androgenic Alopecia: A 16-Week Double-Blind Randomized Controlled Trial

7 citations, January 2015 in “Biological & Pharmaceutical Bulletin”

Rice Bran Supercritical CO2 Extract significantly increased hair density and diameter in male alopecia patients without any side effects.

research Direct Access to Novel Chromeno-Pyrimidine-N-Oxides via Tandem Base Catalyzed Double Nucleophilic Addition/Dehydration Reaction

7 citations, March 2013 in “Tetrahedron Letters”

New method makes important drug ingredients more easily without needing extra purification steps.

Sublingual Minoxidil for the Treatment of Male and Female Pattern Hair Loss: A Randomized, Double-Blind, Placebo-Controlled, Phase 1B Clinical Trial

research Sublingual Minoxidil for the Treatment of Male and Female Pattern Hair Loss: A Randomized, Double-Blind, Placebo-Controlled, Phase 1B Clinical Trial

5 citations, August 2021 in “Journal of The European Academy of Dermatology and Venereology”

Sublingual minoxidil safely promotes hair growth.

Commentary on a Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

research Commentary on a Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

4 citations, March 2016 in “Dermatologic Surgery”

PRP treatment increased hair density, especially in men and younger patients with AGA.

research Detection of Bim and Puma in Mouse Hair Follicles Using Immunofluorescence and TUNEL Assay Double Staining

3 citations, July 2015 in “Biotechnic & histochemistry”

Bim and Puma proteins are found in developing mouse hair follicles and are involved in more than just cell death.

research Alefacept for Severe Alopecia Areata: A Randomized, Double-Blind, Placebo-Controlled Study

3 citations, January 2011 in “Yearbook of Dermatology and Dermatologic Surgery”

Comment on 'Treatment of Male Pattern Alopecia with Platelet-Rich Plasma: A Double-Blind Controlled Study with Analysis of Platelet Number and Growth Factor Levels'

research Comment on 'Treatment of Male Pattern Alopecia with Platelet-Rich Plasma: A Double-Blind Controlled Study with Analysis of Platelet Number and Growth Factor Levels'

2 citations, July 2019 in “Journal of The American Academy of Dermatology”

The comment questions the study's methods for diagnosing hair loss, the type of injections used, the reliability of hair count as a measure, the lack of detail about the procedure, and disagrees with the conclusion about the effect of needling.

research A New Combination of Molecules for the Treatment of Androgenetic Alopecia and Telogen Effluvium: A Double-Blind Randomized, Monocentric, Placebo-Controlled Study

1 citations, January 2022 in “Italian journal of dermatology and venereology”

The combination of arginine and zinc reduces hair loss and increases hair growth effectively.

Efficacy and Tolerability of HDMHG0401-10 in Patients with Androgenetic Alopecia: A Randomized Double-Blind Placebo-Controlled Trial

research Efficacy and Tolerability of HDMHG0401-10 in Patients with Androgenetic Alopecia: A Randomized Double-Blind Placebo-Controlled Trial

1 citations, December 2005 in “임상약리학회지”

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

← Previous page